This intimation is in reference to our intimation dated 09.12.2025, where the number of shares allotted was intimated as 11,45,62,136 instead of 23,000 equity shares of Re. 1/- each under ....

OneSource Specialty Pharma has issued a correction to its earlier intimation dated December 9, 2025, clarifying that only 23,000 equity shares (of Re. 1 each) were allotted under the ONESOURCE ESOP 2021, not 11,45,62,136 shares as previously stated. The shares were allotted to an eligible employee upon exercise of vested stock options at an exercise price of INR 278 per share (premium of INR 277). The new paid-up equity share capital stands at INR 11,45,85,136, comprising 11,45,85,136 equity shares. The newly issued shares rank equally with existing shares and carry no lock-in period. This is a routine ESOP exercise with negligible dilution.